Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials Review uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Pneumonia

abstract

  • Fluoroquinolones were associated with higher success of treatment for severe forms of pneumonia; however, a benefit in mortality was not evident. A randomized controlled trial that includes patients with severe pneumonia with or without bacteremia is needed.

publication date

  • January 2008

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC2585120

Digital Object Identifier (DOI)

  • 10.1503/cmaj.080358

PubMed ID

  • 19047608

Additional Document Info

start page

  • 1269

end page

  • 77

volume

  • 179

number

  • 12